ATTACHMENT #6A
CACC Transgender Policies and Best Practices
An accordance with the NCAA, the CACC believes in and is committed to diversity, inclusion and gender equity among its student-athletes, coaches and administrators. We seek to establish and maintain an inclusive culture that fosters equitable participation for student-athletes and career opportunities for coaches and administrators from diverse backgrounds. Diversity and inclusion improve the learning environment for all student-athletes and enhance excellence within the Conference and the Association.
The development of the following policies and procedures was aided in part by atheNational Center on Lesbian Rightsand theWomen’s Sports Foundationwho provided guidance on how colleges and universities should accommodate the interests of student-athletes who have transitioned or are transitioning from one gender to another. The policies will allow transgender student-athletes to participate in sex-separated sports activities provided the athlete’s use of hormone therapy is consistent with the NCAA policies and current medical standards.
- Participation policies for transgender student-athletesundergoing hormonal treatment for gender transition:
A trans male (FTM) student-athlete who has received a medical exception for treatment with testosterone for diagnosed Gender Identity Disorder or gender dysphoria and/or Transsexualism, for purposes of NCAA competition may compete on a men’s team, but is no longer eligible to compete on a women’s team without changing that team status to a mixed team.
- A female-to-male (FTM) transgender student-athlete who is taking medically prescribed testosterone related to gender transition may not participate on a women’s team after beginning hormone treatment, and must request a medical exception from the NCAA prior to competing on a men’s team because testosterone is a banned substance.
- A female-to-male (FTM) transgender student-athlete who is taking medically prescribed testosterone for the purposes of gender transition may compete on a men’s team.
A trans female (MTF) student-athlete being treated with testosterone suppression medication for Gender Identity Disorder or gender dysphoria and/or Transsexualism, for the purposes of NCAA competition may continue to compete on a men’s team but may not compete on a women’s team without changing it to a mixed team status until completing one calendar year of testosterone suppression treatment.
- A male-to-female (MTF) transgender student-athlete who is taking medically prescribed hormone treatment related to gender transition may participate on a men’s team at any time, but must complete one year of hormone treatment related to gender transition before competing on a women’s team.
- In any case where a student-athlete is taking hormone treatment related to gender transition, that treatment must be monitored by a physician, and the NCAA must receive regular reports about the athlete’s eligibility according to these guidelines.
- Transgender student-athletesNOT taking hormonal treatment related to gender transitionmay participate in sex-separated sports activities in accordance with his or her assigned birth gender.
A trans male (FTM) student-athlete who is not taking testosterone related to gender transition may participate on a men’s or women’s team.
A trans female (MTF) transgender student-athlete who is not taking hormone treatments related to gender transition may not compete on a women’s team.
- Participation on Mixed Teams forTransgender Student-Athletes Taking Hormones
For purposes of mixed gender team classification, a male-to-female (MTF) transgender student-athlete who is taking medically prescribed hormone treatment related to gender transition shall be counted as a male participant until the athlete has completed one year of hormone treatment at which time the athlete shall be counted as a female participant.
For purposes of mixed gender team classification, a female-to-male (FTM) transgender student-athlete who is taking medically prescribed testosterone related to gender transition shall be counted as a male participant and must request a medical exception from the NCAA prior to competing because testosterone is a banned substance.
- Participation on Mixed Teams for Transgender Student-AthletesNOT Taking Hormones
For purposes of mixed gender team classification, a female-to-male (FTM) transgender student-athlete who is not taking testosterone related to gender transition may be counted as either a male or female.
For purposes of mixed gender team classification, a female-to-male (FTM) transgender student-athlete who is not taking testosterone related to gender transition participating on a women’s team shall not make that team a mixed gender team.
For purposes of mixed gender team classification, a male-to-female (MTF) transgender student-athlete who is not taking hormone treatment related to gender transition shall count as a male.
The use of ananabolic agentor peptide hormone must be approved by the NCAA before the student-athlete is allowed to participate in competition while taking these medications. The NCAA recognizes that some banned substances are used for legitimate medical purposes. Accordingly, the NCAA allows exception to be made for those student-athletes with a documented medical history demonstrating the need for regular use of such a drug. Exceptions may be granted for substances included in the following classes of banned drugs: anabolic agents, stimulants, beta blockers, diuretics, anti-estrogens, beta-2 agonists and peptide hormone.
In the event that the student-athlete and the physician (in coordination with sports-medicine staff at the student-athlete's institution) agree that no appropriate alternative medication to the use of the banned substance is available, the decision may be made to continue the use of the medication. However, the use of ananabolic agentor peptide hormone must be approved by the NCAA before the student-athlete is allowed to participate in competition while taking these medications. The institution, through its director of athletics, may request (to the NCAA) an exception for use of an anabolic agent or peptide hormone by submitting to the NCAA medical documentation from the prescribing physician supporting the diagnosis and treatment.